200007133430201 ) 10.1056/NEJM200007133430201 26 Modigliani E Cohen R Campos JM Conte-Devolx B Maes B Boneu A Schlumberger M Bigorgne JC Dumontier P Leclerc L Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in
Search Results
Katerina Saltiki, Elli Anagnostou, George Simeakis, Sofia Kouki, Anastasia Angelopoulou, Leda Sarika, Alexandra Papathoma, and Maria Alevizaki
Morten Winkler Møller, Marianne Skovsager Andersen, Christian Bonde Pedersen, Bjarne Winther Kristensen, and Frantz Rom Poulsen
.1227/01.NEU.0000325725.77132.90 ) 10.1227/01.NEU.0000325725.77132.90 18981881 8 Barzaghi LR Medone M Losa M Bianchi S Giovanelli M Mortini P. Prognostic factors of visual field improvement after trans-sphenoidal approach for pituitary
Yang Lv, Xu Han, Chunyan Zhang, Yuan Fang, Ning Pu, Yuan Ji, Dansong Wang, Xu Xuefeng, and Wenhui Lou
.1016/j.ejca.2008.10.026 13 Yao JC Hassan M Phan A Dagohoy C Leary C Mares JE Abdalla EK Fleming JB Vauthey JN Rashid A, One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United
Changjiao Yan, Meiling Huang, Xin Li, Ting Wang, and Rui Ling
Ahn HY Lee EK Lee YJ Kim KW Hahn SK Youn YK Kim KH , et al . The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis . Cancer 2012 118 . ( https
Shuang Ye, Yuanyuan Xu, Jiehao Li, Shuhui Zheng, Peng Sun, and Tinghuai Wang
poor PFS (HR = 0.393; 95% CI 0.246–0.629; P < 0.001), LRFS (HR = 0.329; 95% CI 0.153–0.704; P = 0.004) and DDFS (HR = 0.346; 95% CI 0.182–0.658; P = 0.001). In addition, Ezrin expression also remained the prognostic factor for DDFS (HR = 0.320; 95
T Szarvas, B Jardin-Watelet, N Bourgoin, M J Hoffmann, P Nyirády, C Oláh, T Széll, A Csizmarik, B Hadaschik, and H Reis
training and validation cohorts ( Table 3 ). In the subgroup of patients who underwent radical cystectomy, sCGA proved to have an independent prognostic factor for OS and DSS in both BC cohorts ( Fig. 2 and Supplementary Table 1, see section on
Ashley K Clift, Oskar Kornasiewicz, Panagiotis Drymousis, Omar Faiz, Harpreet S Wasan, James M Kinross, Thomas Cecil, and Andrea Frilling
institutional case series by Lamarca and coworkers examined prognostic factors in their cohort of 74 patients wherein 64% of those treated with curative intent underwent right hemicolectomy ( 18 ). The group failed to identify any effect of right hemicolectomy
Mélanie Rouleau, Francis Lemire, Michel Déry, Benoît Thériault, Gabriel Dubois, Yves Fradet, Paul Toren, Chantal Guillemette, Louis Lacombe, Laurence Klotz, Fred Saad, Dominique Guérette, and Frédéric Pouliot
Introduction Androgen deprivation therapy (ADT) is used to treat recurrent and advanced PCa ( 1 , 2 ). ADT blocks the testicular production of androgens thus inhibiting PCa cell growth ( 3 ). Serum testosterone levels are a prognostic factor
Filomena Cetani, Chiara Banti, Elena Pardi, Simona Borsari, Paolo Viacava, Paolo Miccoli, Liborio Torregrossa, Fulvio Basolo, Maria Rosa Pelizzo, Massimo Rugge, Gianmaria Pennelli, Guido Gasparri, Mauro Papotti, Marco Volante, Edda Vignali, Federica Saponaro, and Claudio Marcocci
14 patients with any of these negative prognostic factors (64 vs 84%, P =0.337) ( Fig. 5 C). Conversely, the 10-year survival was significantly lower in the former than in the latter group (18 vs 84%, P =0.016). Discussion This study was undertaken
Ichelle Maa van Roessel, Boudewijn Bakker, Hanneke M van Santen, and Wassim Chemaitilly
or prognostic factor in childhood cancer. In non-CCS adults, hyperthyroidism has been associated with increased cancer risk, especially lung, prostate, breast, ovarian and thyroid cancer ( 36 , 38 ). Correlations have also been reported between serum